SHIN NIPPON BIOMED.LAB. earnings per share and revenue

YB3 earnings per share for the last quarter are 0.18 EUR whereas the estimation was 0.17 EUR which accounts for 7.99% surprise. Company revenue for the same period amounts to 43.48 M EUR despite the estimated figure of 33.82 M EUR. Estimated earnings per share for the next quarter are 0.13 EUR, and revenue is expected to reach 50.93 M EUR. Also watch annual changes over time to get a bigger picture of YB3 earnings per share and revenue dynamics.